- Home
- IPSC vs BGSF Comparison
IPSC vs BGSF Comparison
Compare IPSC & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- BGSF
- Stock Information
- Founded
- IPSC 2019
- BGSF 2007
- Country
- IPSC United States
- BGSF United States
- Employees
- IPSC N/A
- BGSF N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- BGSF Professional Services
- Sector
- IPSC Health Care
- BGSF Consumer Discretionary
- Exchange
- IPSC Nasdaq
- BGSF Nasdaq
- Market Cap
- IPSC 47.4M
- BGSF 47.7M
- IPO Year
- IPSC 2021
- BGSF N/A
- Fundamental
- Price
- IPSC $0.59
- BGSF $6.17
- Analyst Decision
- IPSC Strong Buy
- BGSF Strong Buy
- Analyst Count
- IPSC 5
- BGSF 1
- Target Price
- IPSC $3.33
- BGSF $9.00
- AVG Volume (30 Days)
- IPSC 1.0M
- BGSF 294.3K
- Earning Date
- IPSC 08-07-2025
- BGSF 08-06-2025
- Dividend Yield
- IPSC N/A
- BGSF N/A
- EPS Growth
- IPSC N/A
- BGSF N/A
- EPS
- IPSC N/A
- BGSF N/A
- Revenue
- IPSC $114,898,000.00
- BGSF $266,968,000.00
- Revenue This Year
- IPSC $1,590.09
- BGSF N/A
- Revenue Next Year
- IPSC N/A
- BGSF N/A
- P/E Ratio
- IPSC N/A
- BGSF N/A
- Revenue Growth
- IPSC 8286.72
- BGSF N/A
- 52 Week Low
- IPSC $0.34
- BGSF $2.91
- 52 Week High
- IPSC $3.29
- BGSF $9.06
- Technical
- Relative Strength Index (RSI)
- IPSC 55.59
- BGSF 53.87
- Support Level
- IPSC $0.59
- BGSF $6.06
- Resistance Level
- IPSC $0.57
- BGSF $7.65
- Average True Range (ATR)
- IPSC 0.04
- BGSF 0.50
- MACD
- IPSC 0.00
- BGSF -0.12
- Stochastic Oscillator
- IPSC 66.59
- BGSF 34.65
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.